Now my colleague Lars will take over.

Thank you very much.

So I'll go through the results of the trial.

And as you can see here, the trial started in February 2023 and lasted just over three years and was stopped in February this year.

I'll go through the CONSORT diagram in some more detail here.

We screened almost 3,000 patients with in-hospital cardiac arrest, and quite a lot of those did not meet the inclusion criteria, and that specifically was that they did not receive adrenaline or epinephrine.

Most of these were patients with a shock of a rhythm who got out of their cardiac arrest very quickly.

Thank you very much.